- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Most Popular Stocks
Swiss Pharmaceuticals & Biotech Most Popular Stocks
Results
23
Most Popular Stocks on the market
23 companies
Roche Holding
Market Cap: CHF 289.7b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 339.40
7D
3.4%
1Y
24.9%
Novartis
Market Cap: CHF 218.3b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 113.76
7D
3.8%
1Y
24.1%
Lonza Group
Market Cap: CHF 38.8b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 552.00
7D
2.6%
1Y
-0.9%
Galderma Group
Market Cap: CHF 38.7b
Operates as a dermatology company worldwide.
GALD
CHF 163.20
7D
0.7%
1Y
52.6%
Sandoz Group
Market Cap: CHF 26.1b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 60.54
7D
4.7%
1Y
54.9%
Dottikon ES Holding
Market Cap: CHF 5.0b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.
DESN
CHF 360.50
7D
3.4%
1Y
64.6%
Bachem Holding
Market Cap: CHF 4.7b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 62.30
7D
4.0%
1Y
5.6%
Siegfried Holding
Market Cap: CHF 3.5b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 79.60
7D
6.7%
1Y
-19.9%
Tecan Group
Market Cap: CHF 1.8b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 140.20
7D
9.1%
1Y
-37.3%
Cosmo Pharmaceuticals
Market Cap: CHF 1.8b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 110.00
7D
4.6%
1Y
70.0%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 54.90
7D
4.0%
1Y
-29.1%
Kuros Biosciences
Market Cap: CHF 1.1b
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 27.50
7D
0.07%
1Y
17.3%
Idorsia
Market Cap: CHF 937.8m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.76
7D
-11.8%
1Y
373.5%
PolyPeptide Group
Market Cap: CHF 899.0m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 27.25
7D
4.4%
1Y
-4.7%
Basilea Pharmaceutica
Market Cap: CHF 695.5m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 56.60
7D
3.5%
1Y
32.1%
Newron Pharmaceuticals
Market Cap: CHF 569.4m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 28.45
7D
19.3%
1Y
225.9%
MindMaze Therapeutics Holding
Market Cap: CHF 238.1m
Develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MMTX
CHF 1.56
7D
-17.9%
1Y
n/a
Santhera Pharmaceuticals Holding
Market Cap: CHF 181.6m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 13.58
7D
7.8%
1Y
-3.6%
Xlife Sciences
Market Cap: CHF 150.0m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 26.00
7D
5.3%
1Y
0%
BioVersys
Market Cap: CHF 136.8m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 23.40
7D
-4.1%
1Y
n/a
Molecular Partners
Market Cap: CHF 123.8m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.31
7D
-2.2%
1Y
-28.6%
Curatis Holding
Market Cap: CHF 68.0m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 13.20
7D
10.0%
1Y
1.5%
Addex Therapeutics
Market Cap: CHF 6.5m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.055
7D
0%
1Y
-8.0%